Dr. Haneen Abdussalam Khamag, MD

Dr. Khamag practices at Henry Mayo Newhall Hospital in Valencia, California, part of Henry Mayo Newhall Hospital.

Dr. Khamag's NPI, 1346538683, was assigned on July 20, 2011. Dr. Khamag graduated from University of Tripoli School of Medicine in 2005. Dr. Khamag holds California license A127351.

Dr. Khamag's primary practice is Henry Mayo Newhall Hospital, at 23845 McBean Pkwy, Valencia, CA 91355 in Los Angeles County. The practice phone is (661) 253-8000.

Dr. Khamag's primary practice is Henry Mayo Newhall Hospital in Valencia, California, part of Henry Mayo Newhall Hospital. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Khamag to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khamag practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Khamag's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Khamag is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Khamag's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists acute respiratory failure, alzheimer's disease, chronic diabetes, chronic hypertension, chronic kidney disease, chronic respiratory failure, cirrhosis and cirrhosis of the liver among the conditions Dr. Khamag treats.

CMS data shows 375 Medicare services from Dr. Khamag across 6 procedure codes in 2024, for 123 Medicare patients. Medicare paid $37,185 for them.

CMS counts 123 Medicare patients who saw Dr. Khamag in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khamag's median patient age at 69, with 54% women.

In 2024, Dr. Khamag wrote 1,579 Medicare Part D claims for 393 patients. 84% of them were for generic drugs. CMS names the drug for 1,071 of them, across 39 drugs with 11 or more claims each, at $99,685 in total drug cost. In 2023, CMS named 1,009 claims across 37 drugs.

Dr. Khamag accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 25 general payments to Dr. Khamag from 13 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $496.

Dr. Khamag graduated from University of Tripoli School of Medicine in 2005.

Dr. Khamag is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.